In consultation: Guidance and quality standards
Showing 1 to 1 of 1
Title | Consultation | Type | Consultation end date |
---|---|---|---|
Leniolisib for activated phosphoinositide 3-kinase delta syndrome in people 12 years and over [ID6130] | Evaluation consultation | Highly specialised technology |